Funds Fight Bids To Toss $80B Valeant Price-Gouging Suit
A proposed class of Valeant Pharmaceuticals shareholders told a New Jersey federal judge Thursday that all of the claims against the company, its executives and several banks over a price-gouging scheme...To view the full article, register now.
Already a subscriber? Click here to view full article